Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel.

Business Wire • Dec 4, 2025

This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs

New York City-based Cooper Creek Partners bought nearly 4 million shares of The Chemours Company in the third quarter. The shares were worth about $63.1 million at the end of the quarter.

The Motley Fool • Nov 30, 2025

Chemours Q3 Earnings Lag Estimates Amid Operational Disruptions

CC posts a Q3 profit rebound with $60M in net income, driven by strong Thermal & Specialized Solutions amid mixed segment results.

Zacks Investment Research • Nov 11, 2025

Chemours: Solid Momentum Despite One-Time Costs In Q3

Chemours remains challenged by weak end markets, but progress on environmental liabilities and Opteon growth support medium-term prospects. Q3 results were mixed, with disruptions impacting earnings, but the resolution of outages and Opteon gains in the TSS segment provide optimism for improvement. TT segment struggles with weak construction activity, but price increases and supply rationalization should help results bottom in 6–9 months.

Seeking Alpha • Nov 11, 2025

The Chemours Company (CC) Q3 2025 Earnings Call Transcript

The Chemours Company ( CC ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President, CEO & Director Shane Hostetter - Senior VP & CFO Conference Call Participants John McNulty - BMO Capital Markets Equity Research Peter Osterland - Truist Securities, Inc., Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Arun Viswanathan - RBC Capital Markets, Research Division Joshua Spector - UBS Investment Bank, Research Division Patrick Fischer - Goldman Sachs Group, Inc., Research Division Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies LLC, Research Division Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division Vincent Andrews - Morgan Stanley, Research Division Roger Spitz - BofA Securities, Research Division Aaron Rosenthal - JPMorgan Chase & Co, Research Division Presentation Operator Good morning. My name is Gigi, and I'll be your conference operator today.

Seeking Alpha • Nov 7, 2025

Chemours Stock Drops. Here's Why.

Earnings were light, driven by slowing sales of titanium dioxide, a key component of white paint.

Barrons • Nov 7, 2025

The Chemours Company Reports Third Quarter 2025 Results

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Third Quarter 2025 Results.

Business Wire • Nov 6, 2025

Chemours (CC) Q3 Earnings Miss Estimates

Chemours (CC) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.4 per share a year ago.

Zacks Investment Research • Nov 7, 2025

Chemours (CC) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • Nov 7, 2025

Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Oct 30, 2025